Terms of Use
Your access to and use of any material on this Website constitutes your acceptance of, and is conditional upon your acceptance of and compliance with, all of the following terms and conditions. If you do not agree with any of these terms or conditions, do not access or use this Website. YOU ACKNOWLEDGE THAT SISKINDS...
Continue reading the post titled Terms of UseSuboxone (Buprenorphine / Naloxone)
Buprenorphine/Naloxone, marketed as Suboxone®, is a pharmaceutical drug approved in Canada as a substitution treatment in adults with opioid drug dependence, prescribed as a tablet or film that dissolves in the mouth. Buprenorphine — an active ingredient in Suboxone — is reported to increase the risk of dental issues for users. Siskinds LLP and Siskinds’...
Continue reading the post titled Suboxone (Buprenorphine / Naloxone)Study in Canada
If you require a study permit to study in Canada, we will complete an assessment to make sure that you meet the eligibility criteria to apply.
Continue reading the post titled Study in CanadaReceive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.